» Articles » PMID: 35497881

PLAC8 Overexpression Promotes Lung Cancer Cell Growth Via Wnt/-Catenin Signaling

Overview
Journal J Immunol Res
Publisher Wiley
Date 2022 May 2
PMID 35497881
Authors
Affiliations
Soon will be listed here.
Abstract

The PLAC8 expression in lung cancer tissues and in vitro grown lung cancer cells, as well as the involvement of the Wnt/-Catenin signaling pathway, was investigated in this process. PLAC8 protein expression in human lung cancer tissues and lung tumor cells of different strains was discovered using immunohistochemistry staining and Western blot, respectively. Animal models of PLAC8 overexpression and knockdown were created using lentivirus. The development in tumor tissue was seen both in vitro and vivo. The Wnt/-Catenin signaling pathway played an important part in this process, as shown by the dual luciferase reporter gene system. PLAC8 expression was elevated in lung cancer tissues and plasma and decreased in plasma after lung tumor resection. PLAC8 upregulation promotes cell proliferation in vivo and in vitro, while PLAC8 downregulation inhibits cell viability and proliferation. The results of the dual luciferase reporter gene system suggest that PLAC8 can significantly activate the Wnt/-Catenin signaling pathway in cells and can conduct signaling through it. A potential treatment targeting the prognosis of lung cancer patients may be PLAC8 overexpression, which promotes the lung cancer cell proliferation through controlling the Wnt/-Catenin signaling pathway.

Citing Articles

Wnt/β-catenin signaling in the development and therapeutic resistance of non-small cell lung cancer.

Zhang Z, Westover D, Tang Z, Liu Y, Sun J, Sun Y J Transl Med. 2024; 22(1):565.

PMID: 38872189 PMC: 11170811. DOI: 10.1186/s12967-024-05380-8.


A benzochalcone derivative synchronously induces apoptosis and ferroptosis in pancreatic cancer cells.

Guan X, Zhao B, Guan X, Dong J, Ying J PeerJ. 2023; 11:e16291.

PMID: 37927794 PMC: 10625348. DOI: 10.7717/peerj.16291.


Integrated analysis of single-cell and bulk transcriptome identifies a signature based on NK cell marker genes to predict prognosis and therapeutic response in clear cell renal cell carcinoma.

Wang K, Yu M, Zhang Z, Yin R, Chen Q, Zhao X Transl Cancer Res. 2023; 12(5):1270-1289.

PMID: 37304554 PMC: 10248582. DOI: 10.21037/tcr-22-2782.


The Novel-Natural-Killer-Cell-Related Gene Signature Predicts the Prognosis and Immune Status of Patients with Hepatocellular Carcinoma.

Li M, Huang J, Zhan G, Li Y, Fang C, Xiang B Int J Mol Sci. 2023; 24(11).

PMID: 37298537 PMC: 10253630. DOI: 10.3390/ijms24119587.


LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer.

Hao L, Wu W, Xu Y, Chen Y, Meng C, Yun J Molecules. 2023; 28(5).

PMID: 36903369 PMC: 10004581. DOI: 10.3390/molecules28052126.


References
1.
Li M, Liu D, Wang L, Wang W, Wang A, Yao Y . Expression of placenta-specific 8 in human oocytes, embryos, and models of in vitro implantation. Fertil Steril. 2016; 106(3):781-789.e2. DOI: 10.1016/j.fertnstert.2016.05.018. View

2.
Shi L, Xiao L, Heng B, Mo S, Chen W, Su Z . Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma. Int Urol Nephrol. 2017; 49(7):1165-1176. DOI: 10.1007/s11255-017-1578-y. View

3.
Li C, Ma H, Wang Y, Cao Z, Graves-Deal R, Powell A . Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer. J Clin Invest. 2014; 124(5):2172-87. PMC: 4001536. DOI: 10.1172/JCI71103. View

4.
Kinsey C, Balakrishnan V, ODell M, Huang J, Newman L, Whitney-Miller C . Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression. Cell Rep. 2014; 7(4):1143-55. PMC: 4112575. DOI: 10.1016/j.celrep.2014.03.061. View

5.
Jia Y, Ying X, Zhou J, Chen Y, Luo X, Xie S . The novel KLF4/PLAC8 signaling pathway regulates lung cancer growth. Cell Death Dis. 2018; 9(6):603. PMC: 5964121. DOI: 10.1038/s41419-018-0580-3. View